Corporate CUSIP Request Volumes Rise in September

North American corporate CUSIP requests rose 6.5% month over month to 9,100 in September 2026 and were up 10.3% year over year; U.S. corporate equity requests jumped 17.6% for the month and 29.9% year to date. Municipal requests increased 2.0% month over month but were down 1.5% year over year through September. CGS said the rise in requests may signal a rebound in corporate deal activity, though the report is an indicator of issuance activity rather than completed deals.

Analysis

Treat the pickup as a pipeline signal, not booked underwriting revenue: identifier requests can precede completed deals, be delayed, or fail to convert. If confirmed over the next 1–3 months by announced offerings and proceeds, the equity-heavy mix would favor capital-markets franchises such as Goldman Sachs and Morgan Stanley more than lenders whose earnings depend primarily on loan growth. It could also widen the supply of new shares, making deal-heavy sectors more vulnerable to dilution and weak aftermarket performance. The debt signal is less compelling: U.S. corporate debt issuance is only modestly ahead year to date, while municipal bond requests are lower, so this is not yet evidence of a broad financing boom.

The contrarian read is that the large equity-request growth may reflect activity moving from a thin prior-year base or an issuance backlog finally being prepared—not durable risk appetite. Requests are not completed offerings, and the month-to-month measure is noisy. Over 6–18 months, sustained issuance could broaden financing access and support investment, but could also increase equity supply and pressure valuations if demand does not keep pace.

No direct FDS earnings conclusion follows: FactSet manages CGS on behalf of the ABA, but the report provides no evidence that this activity is material to FactSet revenue or margins. Key confirmation points are announced deal count, proceeds, pricing/withdrawals, and capital-markets guidance. A reversal in completed issuance or worsening IPO aftermarket performance would falsify the constructive read.

Key Decisions for Investors

• No immediate trade on the CUSIP report alone. Use it as an alert for a possible capital-markets activity pickup; require actual offering announcements and proceeds before adding exposure.
• If conversion is confirmed over the next 1–3 months, consider a measured relative-value long in Goldman Sachs or Morgan Stanley versus a broad bank basket, rather than a sector-wide bank position. Reassess if deal withdrawals rise or capital-markets guidance fails to improve.
• Avoid treating FDS as a direct beneficiary without evidence of CGS-related revenue or earnings materiality; monitor disclosures rather than trading the headline.
• Track equity issuance alongside IPO pricing and first-month performance. Rising supply with weakening aftermarket returns would favor fading the issuance optimism and would be an early warning that the pipeline is not translating into durable risk appetite.